|
Hydrelle is the first FDA–approved long acting hyaluronic acid filler formulated with an anesthetic (lidocaine) for greater patient comfort. Proven safe and effective, Hydrelle is also a financially attractive alternative to traditional fillers such as Juvéderm® and Restylane®
Hydrelle has been specifically formulated to deliver lasting results comparable to other hyaluronic acid fillers; and the lidocaine anesthetic is integrated, providing a more comfortable injection experience for patients.
Hydrelle represents an attractive value for patients seeking a safe and cost–effective filler option, since patients may not require the same amount as the typical injection volumes, thus requiring fewer syringes to fully correct facial wrinkles. Hydrelle offers patients an advanced, long–lasting dermal filler at an affordable price, particularly during volatile economic times.
Hydrelle is indicated for the correction of moderate to severe facial wrinkles and folds, such as nasolabial folds. In a randomized, controlled pivotal U.S. study of 208 patients, Hydrelle was proven safe and effective. In a multi–center, international study, Hydrelle demonstrated patient and physician satisfaction, and filler effectiveness for up to one year.
|